The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy.

Florence Poizeau Sandrine Kerbrat Frédéric Balusson Pierre TattevinMatthieu RevestVincent Cattoir David Luque Paz Thierry LesimpleMarc PrachtMonica DinulescuDavid RussoEmmanuel Oger Alain Dupuy

Published in: Journal of the National Cancer Institute (2022)

In a large cohort of advanced melanoma patients, we showed that antibiotic use preceding anti-PD-1 antibody was not associated with worse outcome. Physicians should not delay immunotherapy for patients who have recently received antibiotics.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
primary care
peritoneal dialysis